Cardinal Health Stock Loses $912 Million as Recall Searches Test a $63.7 Billion Quarter
Cardinal Health, Inc. lost about $912 million in market value Thursday. Its shares fell 1.67% while the S&P 500 gained 0.73%.
Cardinal Health Shares Fall 4.5% After $60 Million Insider Sales Prompt Questions on Buyback Support
NEW YORK, August 24, 2026, 06:20 EDT — Shares in Cardinal Health declined 4.5% as $60 million worth of insider sales led to scrutiny over whether the company’s buyback program can continue to support the stock price.
NYSE: CAH · Investor Dashboard
Cardinal Health
Insider-sale optics collide with strong guidance and a large repurchase cushion.
U.S. premarket · Aug. 24, 2026
Premarket price
$219.21
06:20 EDT · indicative
Premarket move
−4.49%
From Aug. 21 close of $229.51
From Aug. 11 high
−15.1%
Intraday record: $258.30
Consensus target
$270.94
+23.6% vs premarket · 18 analysts
Post-earnings price path
Daily closes; Aug. 24 is the 06:20 EDT premarket indication.
Scale, not just optics
Executive sales look large. Cardinal's repurchase capacity is much larger.
Six named executive sales
≈$59M
5.9% of planned FY2027 buybacks
Planned FY2027 buybacks
≈$1.0B
About 4.6M shares at $219.21
Total authorization
$6.4B
About 12.5% of guided diluted shares at current price
Investor read: the insider sales are less than 1% of authorization. The harder question is whether cash flow funds the planned repurchases.
Operating scorecard
Latest reported quarter and fiscal 2027 outlook.
Q4 revenue$63.7B+6%
Adjusted EPS$2.91$2.60 ex-refund
FY2027 EPS guide$12.40–$12.60+13%–15%
FY2027 adjusted FCF$3.5B–$4.0Bguide
FY2027 Pharma growth3%–5%revenue
Analyst map
Latest visible targets; all sit above the premarket price.
Barclays · Buy$275+25.5%
RBC · Buy$276+25.9%
J.P. Morgan · Hold$260+18.6%
Deutsche Bank · Hold$261+19.1%
Mizuho · Buy$250+14.0%
What can break the thesis
Buyback timingAuthorization is optional. Purchases may be slower or smaller.
Cash conversionWorking capital can make distributor cash flow volatile.
Operating mixTariffs, acquisitions and specialty volumes can shift margins.
Cardinal Health stock (CAH) climbs after 14% EPS growth forecast offset by 25% decline in cash flow
Shares of Cardinal Health, Inc. climbed 3.6% to $245.64 in premarket trade on Wednesday. The gain brought the stock close to an all-time high after the company provided profit guidance ahead of analysts' expectations. The share movement was seen before the New York market opened.
Cardinal Health Shares Trade at All-Time High After 2027 Outlook Beats Expectations
Cardinal Health, Inc. stock climbed near an all-time high on Tuesday after the drug distributor projected fiscal 2027 earnings ahead of analysts' expectations.
Cardinal Health Shares Reach All-Time High After 2027 Earnings Forecast Surpasses Expectations
Cardinal Health, Inc. approached an all-time high on Tuesday as its updated profit outlook surpassed analyst expectations. Shares advanced 3.6% to $245.64 during morning trade.
Cardinal Health stock today: CAH slips in early trade after forecast hike
Cardinal Health shares fell 0.2% to $226.66 Friday morning, retreating from some of the gains seen after its recent earnings report.
McKesson stock steadies after post-earnings surge as Wall Street rechecks the playbook
McKesson slipped about 0.1% to $956.71 in early New York trade Friday, after surging 16.5% the previous session. Today’s range so far has been between $954.50 and $971.49, data show.
Cardinal Health stock jumps 9% after earnings beat — what CAH investors watch next
Shares of Cardinal Health surged roughly 9% to hit $226.05 in Thursday’s morning session, bouncing back from Wednesday’s $206.85 close.
Cardinal Health (CAH) Stock Pulls Back From Record Highs: Latest News, Forecasts and Investment Outlook as of December 3, 2025
Cardinal Health stock has cooled off after a powerful run in 2025, raising a key question for investors: is this just a healthy pullback, or the start of something more serious?
Cardinal Health (NYSE: CAH) Stock Soars to Record High on Blowout Earnings and Raised Outlook
Cardinal Health’s stock price surged to an all-time high on October 30, 2025, after the company delivered much better-than-expected quarterly results. Shares soared ~13% in one day, briefly trading above $190 intraday and settling around $185 – levels never seen beforeinvesting.com247wallst.com. This spike extended Cardinal’s impressive rally, as investors reacted enthusiastically to the latest earnings and outlook. The one-day jump came amid heavy trading volume and put Cardinal Health among the top gainers on the NYSE that day247wallst.com. The broad market was mixed, making Cardinal’s leap even more noteworthy.
TechStock² Updates
